Information Provided By: 
Fly News Breaks for February 3, 2017
ATHN
Feb 3, 2017 | 09:34 EDT
Baird analyst Matthew Gillmor noted athenahealth reported lower than expected Q4 revenue with the shortfall due to soft utilization, which will catch investors off guard since the company reiterated guidance in December. Gillmor sees the weakness as a buying opportunity as bookings growth for 2017 seems fine. With recurring bookings, its revenue base will support sustainable growth, said Gillmor, who maintained his Outperform rating and $155 price target on athenahealth shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN
